Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons.
暂无分享,去创建一个
A. Rubinstein | D. Blavo | T. Baranowski | Thanh N Doan | Amy L Rubinstein | Timothy C Baranowski | Enid T McKinley | Delali O Blavo | Candace Cato | E. T. Mckinley | Candace Cato | Enid T Mckinley | Thanh Doan
[1] P. Ma. Catecholaminergic systems in the zebrafish. III. organization and projection pattern of medullary dopaminergic and noradrenergic neurons , 1997, The Journal of comparative neurology.
[2] M. Wullimann,et al. The teleostean (zebrafish) dopaminergic system ascending to the subpallium (striatum) is located in the basal diencephalon (posterior tuberculum) , 2001, Brain Research.
[3] M. Ebadi,et al. Neuroprotective actions of selegiline , 2002, Journal of neuroscience research.
[4] T. Dawson,et al. Oxidative Stress and Genetics in the Pathogenesis of Parkinson's Disease , 2000, Neurobiology of Disease.
[5] A. Setini,et al. Molecular characterization of monoamine oxidase in zebrafish (Danio rerio). , 2005, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.
[6] David H. Hall,et al. Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[7] J. Schulz,et al. Parkinson's disease: one biochemical pathway to fit all genes? , 2002, Trends in molecular medicine.
[8] S. Ekker,et al. Effective targeted gene ‘knockdown’ in zebrafish , 2000, Nature Genetics.
[9] T. Sherer,et al. Animal models of Parkinson's disease. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.
[10] J. Postlethwait,et al. Structure of the zebrafish snail1 gene and its expression in wild-type, spadetail and no tail mutant embryos. , 1993, Development.
[11] W. Driever,et al. Mutations in the zebrafish unmask shared regulatory pathways controlling the development of catecholaminergic neurons. , 1999, Developmental biology.
[12] R. Gainetdinov,et al. Dopamine Transporter Is Required for In Vivo MPTP Neurotoxicity: Evidence from Mice Lacking the Transporter , 1997, Journal of neurochemistry.
[13] G. Petzinger,et al. The parkinsonian toxin 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP): a technical review of its utility and safety , 2001, Journal of neurochemistry.
[14] J. Dowling,et al. Small molecule developmental screens reveal the logic and timing of vertebrate development. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[15] J. Langston,et al. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.
[16] H. Pollard,et al. Effect of MPTP on dopaminergic neurons in the goldfish brain: a light and electron microscope study , 1995, Brain Research.
[17] David Blum,et al. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease , 2001, Progress in Neurobiology.
[18] K. Chiba,et al. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. , 1984, Biochemical and biophysical research communications.
[19] Peter T Lansbury,et al. Genetics of Parkinson's disease and biochemical studies of implicated gene products. , 2002, Current opinion in cell biology.
[20] Su Guo,et al. Sensitivity of zebrafish to environmental toxins implicated in Parkinson's disease. , 2004, Neurotoxicology and teratology.
[21] Stuart L Schreiber,et al. Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation , 2004, Nature Biotechnology.
[22] T. Gasser. Genetics of Parkinson's disease , 2001, Journal of Neurology.
[23] S. Parvez,et al. Cell death induced by MPTP, a substrate for monoamine oxidase B. , 2000, Toxicology.
[24] U. Langheinrich,et al. Zebrafish: a new model on the pharmaceutical catwalk. , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.
[25] J. O. Schenk,et al. Kinetic Evaluation of the Commonality Between the Site(s) of Action of Cocaine and Some Other Structurally Similar and Dissimilar Inhibitors of the Striatal Transporter for Dopamine , 1994, Journal of neurochemistry.
[26] F. Vaglini,et al. Species differences in the role of excitatory amino acids in experimental parkinsonism , 1997, Neuroscience & Biobehavioral Reviews.
[27] P. Ma. Catecholaminergic systems in the zebrafish. IV. Organization and projection pattern of dopaminergic neurons in the diencephalon , 2003, The Journal of comparative neurology.
[28] J. Bloch,et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. , 2000, Science.
[29] S. Mandel,et al. MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson’s disease: neuroprotective strategies , 2000, Journal of Neurology.
[30] A. Rubinstein,et al. Zebrafish: from disease modeling to drug discovery. , 2003, Current opinion in drug discovery & development.
[31] P. Ma,et al. Consistency in the number of dopaminergic paraventricular organ-accompanying neurons in the posterior tuberculum of the zebrafish brain , 2003, Brain Research.
[32] F. Menniti,et al. Pramipexole inhibits MPTP toxicity in mice by dopamine D3 receptor dependent and independent mechanisms. , 2003, European journal of pharmacology.
[33] Calum A. MacRae,et al. Drugs That Induce Repolarization Abnormalities Cause Bradycardia in Zebrafish , 2003, Circulation.
[34] Todd B. Sherer,et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.
[35] J. Fetcho,et al. Ontogeny and innervation patterns of dopaminergic, noradrenergic, and serotonergic neurons in larval zebrafish , 2004, The Journal of comparative neurology.
[36] M. Wullimann,et al. Development of the catecholaminergic system in the early zebrafish brain: an immunohistochemical study. , 2002, Brain research. Developmental brain research.
[37] Jan Kaslin,et al. Neurochemical and behavioural changes in zebrafish Danio rerio after systemic administration of 6‐hydroxydopamine and 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine , 2003, Journal of neurochemistry.
[38] E. Rink,et al. The too few mutant selectively affects subgroups of monoaminergic neurons in the zebrafish forebrain , 2004, Neuroscience.
[39] R. Blakely,et al. The Caenorhabditis elegans gene T23G5.5 encodes an antidepressant- and cocaine-sensitive dopamine transporter. , 1998, Molecular pharmacology.
[40] R. Gainetdinov,et al. Plasma membrane monoamine transporters: structure, regulation and function , 2003, Nature Reviews Neuroscience.
[41] V. Korzh,et al. Zebrafish embryos are susceptible to the dopaminergic neurotoxin MPTP , 2005, The European journal of neuroscience.
[42] Erwan Bezard,et al. Absence of MPTP-Induced Neuronal Death in Mice Lacking the Dopamine Transporter , 1999, Experimental Neurology.
[43] A. Levey,et al. Dopamine transporters and neuronal injury. , 1999, Trends in pharmacological sciences.
[44] S. Markey,et al. A parkinsonian syndrome induced in the goldfish by the neurotoxin MPTP , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[45] P. Lansbury,et al. Genetics of Parkinson's disease and biochemical studies of implicated gene products. , 2002, Current opinion in genetics & development.
[46] Wolfgang Driever,et al. Dopamine transporter expression distinguishes dopaminergic neurons from other catecholaminergic neurons in the developing zebrafish embryo , 2001, Mechanisms of Development.